PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35387955-3	2022	Sorafenib is a multi-kinase inhibitor that targets rapidly accelerated fibrosarcoma (RAF), vascular endothelial growth factor receptor (VEGFR)-1, VEGFR-2, VEGFR-3, platelet-derived growth factor receptor-beta (PDGFR-beta), and KIT.	Sorafenib	0-9	KIT proto-oncogene, receptor tyrosine kinase	Canis lupus familiaris	227-230